150 related articles for article (PubMed ID: 33361307)
1. Predicting the Disposition of the Antimalarial Drug Artesunate and Its Active Metabolite Dihydroartemisinin Using Physiologically Based Pharmacokinetic Modeling.
Arey R; Reisfeld B
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361307
[TBL] [Abstract][Full Text] [Related]
2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
[TBL] [Abstract][Full Text] [Related]
4. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
Ericsson T; Blank A; von Hagens C; Ashton M; Äbelö A
Eur J Clin Pharmacol; 2014 Dec; 70(12):1453-63. PubMed ID: 25248945
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
7. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
Xing J; Bai KH; Liu T; Wang RL; Zhang LF; Zhang SQ
Xenobiotica; 2011 Mar; 41(3):252-8. PubMed ID: 21175296
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.
Janse CJ; Waters AP; Kos J; Lugt CB
Int J Parasitol; 1994 Jul; 24(4):589-94. PubMed ID: 8082988
[TBL] [Abstract][Full Text] [Related]
9. Application of Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung and Trachea Exposure of Pyronaridine and Artesunate in Hamsters.
Kang DW; Kim KM; Kim JH; Cho HY
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986698
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and
Anh CX; Chavchich M; Birrell GW; Van Breda K; Travers T; Rowcliffe K; Lord AR; Shanks GD; Edstein MD
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907186
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.
Teja-Isavadharm P; Watt G; Eamsila C; Jongsakul K; Li Q; Keeratithakul G; Sirisopana N; Luesutthiviboon L; Brewer TG; Kyle DE
Am J Trop Med Hyg; 2001 Dec; 65(6):717-21. PubMed ID: 11791963
[TBL] [Abstract][Full Text] [Related]
12. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
Kouakou YI; Tod M; Leboucher G; Lavoignat A; Bonnot G; Bienvenu AL; Picot S
Int J Infect Dis; 2019 Dec; 89():30-44. PubMed ID: 31491558
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
[TBL] [Abstract][Full Text] [Related]
15. Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats.
Li Q; Xie LH; Si Y; Wong E; Upadhyay R; Yanez D; Weina PJ
Int J Toxicol; 2005; 24(4):241-50. PubMed ID: 16126618
[TBL] [Abstract][Full Text] [Related]
16. Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.
Newton P; Suputtamongkol Y; Teja-Isavadharm P; Pukrittayakamee S; Navaratnam V; Bates I; White N
Antimicrob Agents Chemother; 2000 Apr; 44(4):972-7. PubMed ID: 10722499
[TBL] [Abstract][Full Text] [Related]
17. Rectal administration of artemisinin derivatives for the treatment of malaria.
Karunajeewa HA; Manning L; Mueller I; Ilett KF; Davis TM
JAMA; 2007 Jun; 297(21):2381-90. PubMed ID: 17551131
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro/in vivo blood distribution and pharmacokinetics of artemisinin, artemether and dihydroartemisinin in rats.
Dai T; Jiang W; Guo Z; Xie Y; Dai R
J Pharm Biomed Anal; 2019 Jan; 162():140-148. PubMed ID: 30240987
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of artesunate after single oral administration to rats.
Olliaro PL; Nair NK; Sathasivam K; Mansor SM; Navaratnam V
BMC Pharmacol; 2001; 1():12. PubMed ID: 11835690
[TBL] [Abstract][Full Text] [Related]
20. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
